Nadecnemab

Product Description: Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Nadecnemab. Drugbank.

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TGF-β Receptor

• Artikelnummer: MEXHY-P99748-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99748-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated